使用治理框架方法在东盟成员国对耐药结核病的政策分析:一个范围审查
Nicole Rose Alberto1,2, Isabelle Rose I Alberto2, Ianne Keziah Agripo2,3
1Department of Obstetrics and Gynecology, Philippine General Hospital, Manila, Philippines nialberto@up.edu.ph.
BMJ global health
|November 30, 2025
概括
东南亚的耐药结核病 (DR-TB) 政策往往忽视了抗微生物研究和资金. 加强治理和卫生系统对于综合DR-TB护理和普遍医疗保健至关重要.
科学领域:
- 公共卫生 公共卫生
- 卫生政策 卫生政策
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 耐药结核病 (DR-TB) 显著推动了全球抗菌素耐药性 (AMR).
- 东南亚国家联盟 (东盟) 地区面临着巨大的结核病发病率负担.
- 针对DR-TB的现有国家政策需要在AMR治理的背景下进行评估.
研究的目的:
- 评估东盟国家的国家DR-TB政策.
- 应用AMR和WHO卫生系统构建块的治理框架方法.
- 发现DR-TB政策制定和卫生系统加强方面的差距.
主要方法:
- 在官方卫生部和国际组织网站上系统地搜索DR-TB国家政策.
- 分析了118个已识别的政策文件,其中38个被纳入最终数据分析.
- 适用于AMR和世卫组织卫生系统构建块的治理框架.
主要成果:
- 抗微生物研究,公平和药物监管等关键政策领域得到的关注最少.
- 监测和评估,政策设计和实施工具很少被涵盖.
- 卫生工作人员策略是常见的,但融资方案是卫生系统构建块最少解决的问题.
结论:
- 东盟国家DR-TB政策需要一个更全面,更综合的发展体系.
- 加强卫生系统的构建块对于综合DR-TB患者护理至关重要.
- 需要改善政策,以符合普遍医疗保健原则.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
463
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
463
Pulmonary Tuberculosis V
527
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
527
Development of Antibiotic Resistance
1.2K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.2K
Therapeutic Drug Monitoring: Drug Analysis Methods
164
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
164
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182


